Form 4: Medtronic Exec Sells Shares for Tax

Medtronic EVP Michael Marinaro disposed of 1,052 ordinary shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Michael Marinaro, Executive Vice President and President of MedSurg and Americas at Medtronic plc, reported a transaction involving company shares.
• The transaction, dated August 20, 2025, involved the disposition of 1,052 ordinary shares.
• These shares were withheld for the payment of taxes upon the vesting of previously reported restricted stock units.
• The shares were disposed of at a price of $93.22 per share.
• Following this transaction, Michael Marinaro directly beneficially owns 51,939 ordinary shares.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation and tax obligations, which is neither positive nor negative for the company's operational performance or outlook.

Positives

• The executive retains a significant direct holding of 51,939 ordinary shares, indicating continued alignment with shareholder interests.
• The transaction is a routine, non-discretionary event related to standard executive equity compensation.

Negatives

• The disposition of 1,052 shares, while for tax purposes, slightly reduces the executive's direct ownership in the company.

Future Outlook

NA

Industry Context

This type of transaction, involving shares withheld for tax obligations upon the vesting of restricted stock units, is a common and standard practice across all industries for publicly traded companies that provide equity compensation to their executives. It reflects routine executive compensation practices within the healthcare technology sector.

Comparison to Industry Standards

• This transaction is a standard practice for executive equity compensation across publicly traded companies globally, including peers like Johnson & Johnson (JNJ) or Abbott Laboratories (ABT), where executives commonly sell a portion of vested equity to cover tax liabilities. No specific comparable projects or results are relevant here beyond the routine nature of the transaction.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine tax-related transaction and the executive retains a substantial holding.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and do not typically reflect a change in the company's fundamentals or the executive's confidence, thus not warranting a change from a 'hold' recommendation.

Keywords

Medtronic, MDT, Michael Marinaro, Form 4, insider transaction, share disposition, restricted stock units, RSU, executive compensation, tax withholding